seven patients with a normal ambulatory electrocardiogram, none had appreciable arrhythmia shown by the Cardiomemo; three, however, confirmed sinus rhythm during a symptom; and four failed to transmit.
Discussion
Our findings show that the Cardiomemo does not offer any important advantage over ambulatory electrocardiography in the diagnosis of symptomatic arrhythmias in unselected patients; this is in contrast with a previous report.4 The theoretical advantage of the Cardiomemo is the documentation of infrequent or sporadic episodes directly related to symptoms. The Cardiomemo proved useful in this respect in three patients, in whom the symptoms repeatedly occurred in sinus rhythm. In general, however, the Cardiomemo was less useful in documenting arrhythmia in patients with rare symptoms than ambulatory electrocardiography.
Several problems arose with the use of the Cardiomemo, resulting in eight patients making no transmissions despite symptomatic arrhythmias having been documented by ambulatory electrocardiography. Despite its apparently simple operation some patients found the device difficult to use. In other cases it was not immediately to hand when the symptoms occurred. Another major limitation of the Cardiomemo was the small number of patients one device could benefit; in our study the device was kept by patients for an average of 21 days. Thus only 17 patients could benefit from each device during one year. In the study of infrequent symptoms even fewer patients could be evaluated. Although the Cardiomemo and decoder device are substantially cheaper than the equipment required for ambulatory electrocardiography, a large number of Cardiomemos would be required to achieve an adequate patient workload. In these times of austerity, however, the Cardiomemo might in smaller units be a suitable alternative to a full scale ambulatory monitoring service, which may be prohibitively expensive and consequently denied.
Unlike ambulatory electrocardiography the Cardiomemo cannot easily detect arrhythmias either associated with syncope or unrelated to symptoms, yet these may have important prognostic implications. This disadvantage can be partly overcome if the patient has a partner to apply the Cardiomemo during syncope and also makes routine transmissions once or twice a day.
In conclusion, the usefulness of the Cardiomemo seems to be restricted to those few patients with a 24 hour electrocardiogram that is normal or at variance with the clinical diagnosis and possibly to those units that do not have sufficient financial resources. The results of this study show, however, that the Cardiomemo can be useful in confirming the absence of arrhythmia during symptoms; this may be reassuring for anxious patients.
